Want to join the conversation?
Biopharma company $PFE said Prevnar 13 has received US FDA approval for an expanded age indication to include adults 18 through 49 years of age, in addition to already approved adults 50 years and older, for active immunization for prevention of pneumonia and invasive disease caused by 13 Streptococcus pneumoniae serotypes.
$WTW Great marketing execution and overwhelming response to the development strategy is seeing the stock boom. Biggest intraday gain ( 30%) since Nov. 2015. Hats off to Oprah Winfrey !!
$HSY is planning to cut its global workforce by 15%.
$ACN spreading its arms!! Now into pipeline network and emergency management services, thanks to the latest Davies Consulting buy.